Publications

Export 12 results:
Author Title Type [ Year(Desc)]
Filters: Author is Cervantes, Pablo  [Clear All Filters]
2015
Parikh SV, Hawke LD, Velyvis V, Zaretsky A, Beaulieu S, Patelis-Siotis I, MacQueen G, L Young T, Yatham LN, Cervantes P.  2015.  Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder.. Bipolar Disord. 17(1):86-96.
2016
Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM et al..  2016.  Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.. Lancet. 387(10023):1085-93.
Hou L, Bergen SE, Akula N, Song J, Hultman CM, Landen M, Adli M, Alda M, Ardau R, Arias B et al..  2016.  Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.. Hum Mol Genet. 25(15):3383-3394.
2018
Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K et al..  2018.  Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.. Front Psychiatry. 9:207.
Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu Y-H, Shekhtman T et al..  2018.  Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.. JAMA Psychiatry. 75(1):65-74.
Soh JFotso, Torres-Platas SG, Beaulieu S, Mantere O, Platt R, Mucsi I, Saury S, Renaud S, Levinson A, Andreazza AC et al..  2018.  Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.. BMC Psychiatry. 18(1):227.
Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, Adli M, Adorjan K, Akula N, Alda M et al..  2018.  Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.. Bipolar Disord.
2020
Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu Y-H et al..  2020.  Association of polygenic score for major depression with response to lithium in patients with bipolar disorder.. Mol Psychiatry.
Soh JFotso, Beaulieu S, Trepiccione F, Linnaranta O, Torres-Platas G, Platt RW, Renaud S, Su C-L, Mucsi I, D'Apolito L et al..  2020.  A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users.. Bipolar Disord.
Soh JFotso, Almadani A, Beaulieu S, Rajji T, Mulsant BH, Su C-L, Renaud S, Mucsi I, S Torres-Platas G, Levinson A et al..  2020.  The effect of atorvastatin on cognition and mood in bipolar disorder and unipolar depression patients: A secondary analysis of a randomized controlled trial.. J Affect Disord. 262:149-154.
2021
Schubert KOliver, Thalamuthu A, Amare AT, Frank J, Streit F, Adl M, Akula N, Akiyama K, Ardau R, Arias B et al..  2021.  Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients.. Transl Psychiatry. 11(1):606.
Le Clerc S, Lombardi L, Baune BT, Amare AT, Schubert KOliver, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U et al..  2021.  HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders.. Sci Rep. 11(1):17823.